January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the ...
January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical ...
November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...
November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...
November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...
November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system error ...
October 11, 2019 — The ultra-thin Supraflex drug-eluting stent (DES) from SMT maintained numerically lower outcomes at ...
October 9, 2019 — Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received ...
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...